Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)

Enrolling by invitationOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Age-Related Macular Degeneration
Trial Locations (8)

1090

Medical University of Vienna, Vienna

CM20 1QX

The Princess Alexandra Hospital Nhs Foundation Trust, Harlow

SO16 6YD

University Hospital Southampton, Southampton

PO30 5TG

St Mary's Hospital, Newport

OX3 9DU

John Radcliffe Hospital, Oxford

GU16 7UJ

Frimley Health Nhs Foundation Trust, Frimley

SP2 8BJ

Salisbury Nhs Foundation Trust, Salisbury

EC1V 2PD

Moorfields Eye Hospital, London

All Listed Sponsors
collaborator

King's College London

OTHER

collaborator

Imperial College London

OTHER

collaborator

Medical University of Vienna

OTHER

collaborator

University of Michigan

OTHER

collaborator

University College, London

OTHER

collaborator

University Hospital, Basel, Switzerland

OTHER

lead

University of Southampton

OTHER

NCT06682455 - Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2) | Biotech Hunter | Biotech Hunter